Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study
Karl Swedberg, Michel Komajda, Michael Böhm, Jeffrey Borer, Ian Ford, Ariane Dubost-Brama +2 more
The Lancet
Concepts
IvabradineMedicineHeart failurePlaceboClinical endpointEjection fractionInternal medicineHeart rate